Meibomian gland dysfunction and dry eye Diagnosis and treatment

被引:6
作者
Kovacs Balazs [1 ]
Lang Boglarka [2 ]
Takacsi-Nagy Anna [2 ]
Horvath Gyorgyi [3 ]
Czako Cecilia [4 ]
Csorba Anita [4 ]
Kiss Huba [4 ]
Szalai Iren [4 ]
Nagy Zoltan Zsolt [4 ,5 ]
Kovacs Illes [4 ,5 ]
机构
[1] Kaposi Mor Megyei Korhaz, Szemeszeti Osztaly, Kaposvar, Hungary
[2] Pecsi Tud Egyet, Gyogyszeresztud Kar, Gyogyszertechnol & Biofarmaciai Int, Pecs, Hungary
[3] Pecsi Tud Egyet, Gyogyszeresztud Kar, Farmakognoziai Int, Pecs, Hungary
[4] Semmelweis Egyet, Altalanos Orvostud Kar, Szemeszeti Klin, Budapest, Hungary
[5] Semmelweis Egyet, Egeszsegtud Kar, Budapest, Hungary
关键词
Meibomian gland dysfunction; dry eye; Demodex mites; INTERNATIONAL WORKSHOP; LID HYGIENE; FATTY-ACIDS; IN-VITRO; DEMODEX; SUBCOMMITTEE; THERAPY; MANAGEMENT; EFFICACY; BLEPHARITIS;
D O I
10.1556/650.2021.31958
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The onset of dry eye complaints is often a result of Meibomian gland dysfunction and its diagnosis is essential for effective treatment. In the case of Meibomian gland dysfunction, there is an increased evaporation of the tear film due to the abnormal secretion of lipids that cannot spread on the ocular surface. The treatment of dry eye complaints associated with Meibomian gland dysfunction with tear supplementation is usually ineffective and only results in an intermittent relief of complaints. Meibomian gland dysfunction is often associated with Demodex infestation of the eyelids, and eradicating the mites is essential to re-establish normal meibum production and thus, decreasing ocular complaints. In most cases, Meibomian gland dysfunction is mild, and the treatment of these forms is based on ocular hygiene performed by the patient, while only more advanced forms with inflammatory processes require pharmacologic treatment. This review summarizes the most important knowledge on the clinical signs and treatment of Meibomian gland dysfunction with particular attention to the diagnosis and treatment of ocular Demodex infection.
引用
收藏
页码:43 / 51
页数:9
相关论文
共 50 条
[1]   Efficacy of Topical N-Acetylcysteine in the Treatment of Meibomian Gland Dysfunction [J].
Akyol-Salman, Ilknur ;
Azizi, Sedat ;
Mumcu, Ugur ;
Baykal, Orhan .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (04) :329-333
[2]   Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction [J].
Arita, Reiko ;
Fukuoka, Shima ;
Morishige, Naoyuki .
OCULAR SURFACE, 2019, 17 (01) :104-110
[3]   Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction [J].
Arita, Reiko ;
Morishige, Naoyuki ;
Shirakawa, Rika ;
Sato, Yoichi ;
Amano, Shiro .
OCULAR SURFACE, 2015, 13 (04) :321-330
[4]   Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: A randomized clinical trial [J].
Avila, Marcel Y. ;
Martinez-Pulgarin, Dayron F. ;
Madrid, Carolina Rizo .
CONTACT LENS & ANTERIOR EYE, 2021, 44 (03)
[5]   New international consensus statement about the definition, classification, ethiology, diagnostics and therapy of dry eye (TFOS DEWS II) [J].
Berta Andras ;
Toth-Molnar ;
Csutak Adrienne .
ORVOSI HETILAP, 2018, 159 (20) :775-785
[6]   Human Meibum Lipid Conformation and Thermodynamic Changes with Meibomian-Gland Dysfunction [J].
Borchman, Douglas ;
Foulks, Gary N. ;
Yappert, Marta C. ;
Bell, James ;
Wells, Emily ;
Neravetla, Shantanu ;
Greenstone, Victoria .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (06) :3805-3817
[7]  
Bron AJ, 2007, OCUL SURF, V5, P108
[8]   Polyunsaturated fatty acids, inflammation, and immunity [J].
Calder, PC .
LIPIDS, 2001, 36 (09) :1007-1024
[9]  
Coston T O, 1967, Trans Am Ophthalmol Soc, V65, P361
[10]   Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction [J].
Cote, Sharlotta ;
Zhang, Alexis Ceecee ;
Ahmadzai, Victoria ;
Maleken, Amina ;
Li, Christine ;
Oppedisano, Jeremy ;
Nair, Kaavya ;
Busija, Ljoudmila ;
Downie, Laura E. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (03)